Guardian Pharmacy Services Inc. Class A (GRDN)
NYSE: GRDNConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GRDN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.97B
- P/E (TTM)
- 40.12
- Forward P/E
- 31.26
- EPS (TTM)
- $1.17
- Dividend yield
- None
- 52-week range
- 26.34 – 50.85
- Day range
- 46.13 – 47.48
- Volume / Avg
- 526.70K / 547.39K
- Beta
- —
- Shares outstanding
- 63.32M
52-week range
GRDN stock today
Shares of Guardian Pharmacy Services (GRDN) finished higher on Nov 20 at $46.94, a gain of 0.58% or $0.27 per share, versus the S&P 500's 3.70% decline. Shares are 7.7% below their 52-week high of $50.85, set on Nov 17, 2026 and 78.2% above the 52-week low of $26.34, near the top of the past year's range. GRDN is up 56.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 65.5%.
Guardian Pharmacy Services trades at 40.1x its trailing twelve-month earnings per share of $1.17. Its forward P/E of 31.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Guardian Pharmacy Services
Company profileGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- CEO
- Mr. Fred P. Burke
- Headquarters
- Atlanta, GA
- Employees
- 3,600
- IPO year
- 2024
- Website
- guardianpharmacy.com
Financial highlights
Full financialsIn fiscal 2025, Guardian Pharmacy Services generated $1.45 billion in revenue, up 17.9% from fiscal 2024. Net income was $49.2 million, for a net margin of 3.4% versus a median of -9.0% in the prior 1 years. Gross margin was 20.2% (up from 19.9%) and operating margin 5.0%.
| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Revenue | $1.45B | $1.23B |
| Growth | +17.93% | — |
| Net income | $49.22M | $-110.05M |
| EPS (diluted) | — | — |
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$50.14+6.82%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.29 vs $0.28
- Surprise
- +3.57%
GRDN news
All GRDN news- Guardian Pharmacy Services Reaches Analyst Target PriceNasdaqGRDN, MOG.A
- NBIX or GRDN: Which Is the Better Value Stock Right Now?NasdaqNBIX, GRDN
- NBIX vs. GRDN: Which Stock Is the Better Value Option?NasdaqNBIX, GRDN
- Guardian Pharmacy Services Non-GAAP EPS of $0.33 beats by $0.02, revenue of $371.1M beats by $5.34MSeeking Alpha
- Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year GuidanceBusiness Wire
- Guardian Pharmacy Services Acquires Van’s Institutional Pharmacy, Expanding Footprint in Tennessee and KentuckyBusiness Wire
- Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference CallBusiness Wire
Guardian Pharmacy Services peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| YI111 Inc. ADR | 2.36 | -5.98% | $20.76M | vs GRDN |
| PETSPetMed Express Inc. | 0.8501 | -8.04% | $18.90M | vs GRDN |
| RDGTRidgetech Inc. | 0.94 | -7.44% | $3.41M | vs GRDN |
| CVSCVS Health Corporation | 80.84 | +1.00% | $103.43B | vs GRDN |
Indexes, lists and sector
Largest Consumer Staples stocks
Guardian Pharmacy Services stock FAQ
What is Guardian Pharmacy Services's stock price today?
GRDN last traded at $46.94 as of Nov 20, 4:00 PM EST, up 0.58% on the day. Prices are delayed at least 15 minutes.
What is GRDN's P/E ratio?
GRDN trades at a trailing P/E ratio of 40.12 and a forward P/E of 31.26.
Who is Guardian Pharmacy Services's CEO?
Mr. Fred P. Burke is the chief executive officer of Guardian Pharmacy Services Inc. Class A, which has about 3,600 employees.
What is the GRDN 52-week high?
The 52-week high for GRDN is $50.85 and the 52-week low is $26.34. The stock is currently 7.7% below its high.